Jurgen Zieren
Dortmund, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Corrigendum to "Safety of secondary CRS/HIPEC in peritoneal surface malignancies: Insights from a national cohort study" [Eur J Surg Oncol 52 (2026) 111408].
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: March 15, 2026
Safety of secondary CRS/HIPEC in peritoneal surface malignancies: Insights from a national cohort study.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: November 02, 2025
First Clinical Safety and Feasibility Data of Whole-body Hyperthermia Pressurized Intraperitoneal Aerosol Chemotherapy (WBH-PIPAC) for Peritoneal Surface Malignancies.
Journal: Anticancer research
Published: May 04, 2024
Safety and Feasibility of High-Pressure/High-Dose Pressurized Intraperitoneal Aerosol Chemotherapy (HP/HD-PIPAC) for Primary and Metastatic Peritoneal Surface Malignancies.
Journal: Annals of surgical oncology
Published: July 21, 2022
Hyperthermic intracavitary nanoaerosol therapy (HINAT) as an improved approach for pressurised intraperitoneal aerosol chemotherapy (PIPAC): Technical description, experimental validation and first proof of concept.
Journal: Beilstein journal of nanotechnology
Published: August 23, 2017
Erratum to: Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells.
Journal: World journal of surgical oncology
Published: April 20, 2017
Scintigraphic peritoneography reveals a non-uniform 99mTc-Pertechnetat aerosol distribution pattern for Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a swine model.
Journal: Surgical endoscopy
Published: November 14, 2016
Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model.
Journal: Journal of cancer research and clinical oncology
Published: August 22, 2016
Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells.
Journal: World journal of surgical oncology
Published: July 27, 2016
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Journal: World journal of surgical oncology
Published: July 21, 2016
Evaluating the Effect of Micropump© Position, Internal Pressure and Doxorubicin Dosage on Efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model.
Journal: Anticancer research
Published: June 26, 2016
Technical description of the microinjection pump (MIP®) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Journal: Surgical endoscopy
Published: February 29, 2016
Last Updated: 09/26/2026